PDF-How to investigate the use of medicines by consumersWORLD HEALTH ORGAN

HOW TO INVESTIGATE THE USE OF MEDICINES BY CONSUMERS WHO ROYAL TROPICALINSTITUTE WHOEDMPAR20042 How to investigate the use of medicines by consumers Anita HardonUniversity of AmsterdamThe Netherla. Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. Presented by . Deirdre Dimancesco. Department of Essential Medicines and . H. ealth Products, WHO. at the . Technical Briefing Seminar. 15 April, 2013 . MeTA. aim. MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and policy dialogue among stakeholders.. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . PARTNERSHIP. Medicines for Europe Vision 2020 . Our 5 pillars. 2. PATIENTS. Medicines For Europe . VISION. QUALITY. VALUE. SUSTAINABILITY. Pressure on EU budgets . Reduction. of . healthcare. . spending. Emmanuel Kwesi Eghan . Center . for Pharmaceutical Management (CPM. ). Management Sciences for Health . Emanuel Kwesi Eghan. Center for Pharmaceutical Management . Management Sciences for Health ( MSH) . IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Lesson objective – to learn how . disease is researched and defined . Task 1 – in groups of two or three . Research and investigate patterns of disease or ill health from the chosen cards . Breast Cancer . Strategic Plan Development – . Feed-back from the WHA 67. th. . IPC Meeting. WHO Geneva, June 04 - 06. WHO medicines & technologies 2014-2019 strategy / action plan. GPW : 6 leadership priorities . and. Dominic Goodwin, Project Co-ordinator, WA Drug Evaluation Panel. The WA SMF - Vision. To . deliver optimal patient outcomes in an equitable manner through a single list of approved medicines for all WA public hospitals; evaluated, implemented and managed in a . Strategic Plan Development – . Feed-back from the WHA 67. th. . IPC Meeting. WHO Geneva, June 04 - 06. WHO medicines & technologies 2014-2019 strategy / action plan. GPW : 6 leadership priorities . Presented by . Deirdre Dimancesco. Department of Essential Medicines and . H. ealth Products, WHO. at the . Technical Briefing Seminar. 15 April, 2013 . MeTA. aim. MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and policy dialogue among stakeholders.. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. IPC Meeting . 4 to 6 . June. 2014. Essential Medicines and Health Products Department (EMP) . . . October. 2013. . Office of the . Dr. Richard Torbett. Chief Economist, EFPIA. China/ EU Pharmaceutical Industry Forum. Shanghai, . 16 May 2015. Policy debate on health in recent years has been dominated by cost containment. Health & Growth.